The global semaglutide industry is expected to be restricted due to the risk of a potential medicine shortage for medical purposes
Setting this expectation honestly matters
E11.9 Type 2 diabetes mellitus without complications Use when: The patient has Type 2 diabetes without complications, and Ozempic is prescribed for glycemic control
However, athletes, in particular, have an increased energy demand, but often prefer high-carb diet and even forego meat entirely
Particularly helpful when training-induced inflammation is elevated due to slower recovery
Projected to grow at a CAGR of over 6.5%, reaching USD 83.2 billion by 2027 [2], this market reflects a growing awareness of the interconnectedness of health, wellness, and aging